Top Stories

More EU countries halt AstraZeneca shot as EMA reviews side effects


An army health worker prepares a dose of Covishield, AstraZeneca/Oxford’s Covid-19 coronavirus vaccine made by India’s Serum Institute, at an army hospital in Colombo on January 29, 2021.

ishara S. Kodikara | AFP | Getty Images

LONDON — Two additional countries opted to suspend the use of the AstraZeneca vaccine in Europe on Tuesday due to blood clot concerns, as regulators proceeded with a new review into its side effects.

Sweden and Latvia announced on Tuesday morning that they were pausing their rollout of the AstraZeneca vaccine, developed with the University of Oxford. Portugal, Luxembourg and Slovenia took the decision to halt use of the shot on Monday night. Earlier in the day,…


As Fed meets, Wells Fargo predicts 10-year yield could reach 2.25%

Previous article

Dick’s Sporting Goods launches men’s athleisure line VRST

Next article

You may also like

Leave a Reply

Notify of

More in Top Stories